Summit Wealth Group (Colorado)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Summit Wealth Group (Colorado)'s LLY Position: Q3 2026 in Review
Summit Wealth Group (Colorado) increased its Eli Lilly (LLY) stake by 71% in Q3 2026, buying an estimated $1.87M and bringing the position to 3,803 shares worth $4.4M. The position accounts for 0.28% of the portfolio, ranked #50.
Summit Wealth Group (Colorado) first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Summit Wealth Group (Colorado) held 3,803 shares of Eli Lilly worth $4.4M as of Q3 2026.
- Summit Wealth Group (Colorado) bought 1,581 Eli Lilly shares in Q3 2026, an estimated $1.87M.
- Eli Lilly made up 0.28% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #50 holding.
- Summit Wealth Group (Colorado) first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.